Frederick W. Driscoll, Director at Cellectar Biosciences, Inc. (CLRB), bought 19,417 shares at $1.04 ($20K) on 2021-09-03, disclosed to the SEC on 2021-09-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| MEIP | BUY | 2019-12-20 | $100K | — | Filing → |
| FLXN | SELL | 2017-03-24 | $69K | — | Filing → |
| FLXN | SELL | 2017-03-02 | $1.3M | — | Filing → |